Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MyoKardia Inc. MYOK

Healthcare Biotechnology
"MyoKardia Inc is a US-based clinical-stage biopharmaceutical company which is engaged in discovering, developing and commercializing targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. The company mainly focuses on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac... see more

Recent & Breaking News (NDAQ:MYOK)

MyoKardia Announces Positive Results from Low-Dose Cohort of Phase 2 PIONEER-HCM Study of Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients

GlobeNewswire March 8, 2018

MyoKardia, Inc. to Host Earnings Call

Accesswire March 8, 2018

Earnings Preview For MyoKardia

Benzinga.com  March 8, 2018

MyoKardia to Present at the Cowen and Company 38th Annual Health Care Conference

GlobeNewswire March 6, 2018

MyoKardia to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 8, 2018

GlobeNewswire March 1, 2018

MyoKardia Announces Appointment of Cynthia Ladd as General Counsel

GlobeNewswire January 19, 2018

MyoKardia to Present at 36th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 3, 2018

Preclinical Studies with MyoKardia’s Mavacamten Demonstrate Evidence of Reduced Contractility and Improved Left Ventricular Compliance

GlobeNewswire November 15, 2017

MyoKardia Presents Data from Study of Machine Learning Algorithm Intended to Identify Obstructive Hypertrophic Cardiomyopathy Using a Wearable Biosensor

GlobeNewswire November 13, 2017

MyoKardia Reports Third Quarter 2017 Financial Results and Operational Progress

GlobeNewswire November 2, 2017

MyoKardia Announces Presentations at 2017 American Heart Association Scientific Sessions

GlobeNewswire November 1, 2017

MyoKardia to Present at Two Upcoming Investor Conferences in November

GlobeNewswire October 31, 2017

MyoKardia to Announce Third Quarter 2017 Financial Results on Thursday, November 2, 2017

GlobeNewswire October 26, 2017

Stock Performance Review on Biotech Industry -- MyoKardia, Nabriva Therapeutics, Puma Biotechnology, and PDL BioPharma

PR Newswire October 26, 2017

MyoKardia Provides Update on MYK-491 Clinical Progress

GlobeNewswire September 27, 2017

MyoKardia Presents Additional Positive Data from Phase 2 PIONEER-HCM Study of Mavacamten (Formerly MYK-461) at the Heart Failure Society of America’s 21st Annual Scientific Meeting

GlobeNewswire September 18, 2017

MyoKardia to Present at Two Upcoming Investor Conferences in September

GlobeNewswire August 30, 2017

MyoKardia Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares

GlobeNewswire August 14, 2017

MyoKardia Announces Pricing of Public Offering of Common Stock

GlobeNewswire August 8, 2017

MyoKardia Announces Proposed Public Offering of Common Stock

GlobeNewswire August 7, 2017